Top news of the week: 02.09.2022.
MassBio’s Industry Snapshot Shows Massachusetts-Headquartered Biopharma Companies Raised 4th Highest Annual Total in Just the First Half of 2022
CAMBRIDGE, MA – August 30, 2022 – The Massachusetts Biotechnology Council (MassBio®) today released its 2022 Industry Snapshot, which shows significant growth across the life sciences ...
Biopharma Needs Protect more than Crown Jewel IP Stay Competitive
The problem of intellectual property theft is greater than most biopharma executives realize, but the real issue is that companies are protecting only a fraction of their IP.
Organoids Move One Step Closer to Human Kidneys
A highly efficient method generates differentiation of hPSCs into ureteric bud (UB) organoids which mature into the adult kidney.
Avance Clinical Sponsors Biotech Company of the Year Awards at Informa Pharma Intelligence Awards 2022
ADELAIDE, AUS, Aug 29, 2022 - (ACN Newswire) - Avance Clinical, the leading Australian CRO for international biotechs, is sponsoring two awards - Biotech ...
David Baker’s lab and ARCH sprout Lord of the Rings-inspired macrocycle biotech
For drugs to succeed as pills, they have to meet a few requirements. First, they have to be able to brave the gnawing acids of the gut. Second, they have to survive the protein-butchering ...
Trapped in Nasdaq’s biotech basement, Codiak’s Doug Williams lays out a survival plan: chopping jobs, PhII plans
It took a dogged effort by Codiak BioSciences $CDAK founder Doug Williams to get an IPO to fly on Nasdaq. But once out in late 2020 at $15, he was embraced by a new generation of biotech ...
Ginkgo Bioworks Appoints Dr. Behzad Mahdavi as Senior Vice President of Biopharma Manufacturing & Life Science Tools
Ginkgo Bioworks Appoints Dr. Behzad Mahdavi as Senior Vice President of Biopharma Manufacturing & Life Science Tools - read this article along with other careers information, tips and ...
ABIVAX: Abivax announces successful oversubscribed EUR 49.2M cross-over financing with top-tier US and European Biotech investors
DGAP-News: ABIVAX / Key word(s): MiscellaneousABIVAX: Abivax announces successful oversubscribed EUR 49.2M cross-over financing with top-tier US and European Biotech investors 02.09.2022 / ...